burtlancast
Member
- Joined
- Jan 1, 2013
- Messages
- 3,263
This is interesting:
Cancer: Disorder and Energy
"The alkaline cancer cell surrounds itself by the acid that it emits, and this extracellular acidity increases the ability of fatty acids to enter the cell (Spector, 1969); cancer cells, although they are synthesizing fat, also avidly take it up from their environment (Sueyoshi and Nagao, 1962b). This fat avidity is so extreme that cancer cells in vitro will eat enough polyunsaturated fat to kill themselves.
Nice.
In this thread, (Dr. Emanuel Revici Used Fatty Acids To Kill Cancer) there's a rare video of Revici explicitly stating his most important discovery during his 70 years career lies in the fact tumors contain free fatty acids, and that one can thus target tumors by incorporating diverse molecules ( mainly sulfur) into fatty acids which will be selectively captured by them.
In this patent, he chooses to incorporate potassium.Patent US4649152 - Composition and method for treatment of potassium deficiency
He states that the most favorable oil to be used is polyunsaturated vegetable oil.
"TECHNICAL FIELD
The present disclosure concerns a method to treat various conditions resulting from potassium deficiency and preparations for same.
BACKGROUND
It is known that the abnormal cells in general and the neoplastic cells in particular are poor in potassium, a fact which is considered as including and enhancing their abnormal character. It is also known that the blood plasma of subjects with such abnormal conditions is especially rich in potassium, apparently due to the body's attempt to correct the cellular potassium deficiency. The form under which the potassium is circulating in the blood, that is, mainly as ceruloplasmin, however, is not the proper form from which the potassium can be taken by the abnormal cells.
SUMMARY OF THE INVENTION
The invention comprises novel compositions of fatty acids, ester, or oils which include potassium incorporated therein. These composition are made by heating the oil component to a temperature of at least above 230° C. for a sufficient time to incorporate a predetermined amount of potassium into the oil. At least about 0.1% can be used, although between 1 and 10% is preferred.
These compositions of the invention may be administered to a patient who has cells or tissue which are deficient in potassium to increase the potassium content as well as to treat the symptoms of diseases or adverse effects caused by the potassium deficient cells or tissue.
DETAILED DESCRIPTION OF THE INVENTION
I have found that in general, the abnormal cells and tissues in the body have free lipids. Thus, a lipid or compound having a lipidic character introduced into the body can be selectively taken by the abnormal cells. Accordingly, it is believed that a potassium compound having lipidic properties is useful as a therapeutic agent for patients who have such abnormal cells.
I have found that potassium can be incorporated in the molecule of a fatty acid by heating together an organic or inorganic salt of potassium with a fatty acid or its oil. Preferably, the fatty acid or oil is previously oxidized by being heated and mixed with air or oxygen. The mixtures of potassium and fatty acids or oil are heated at a temperature above about 230° C. for a time until an exothermic reaction is observed, which reaction indicates that the incorporation is taking place.
The allylically unsaturated compound is preferably a naturally occurring oil containing polyunsaturated fatty esters, such as an animal, vegetable, or fish oil, and, particularly, polyunsaturated vegetable oils. Sesame oil, a vegetable oil consisting largely of triglycerides, is the most advantageous composition found to date in the practice of this invention.
The products obtained have the potassium incorporated in general at the level of the double bonds of the different unsaturated fatty acids, this causes their toxicity to be exceptionally low. The injection of 1 ml of a product having 5% potassium to a mouse does not kill it.
The incorporated potassium is believed to be absorbed by the abnormal cells, thus compensating for their low potassium content. This treatment produces objective and subjective improvement in the conditions, of patients having a variety of diseases based upon such abnormal cells. The neoplastic diseases are examples of diseased in which low cellular potassium abnormal cells are found.
Such low cellular potassium abnormal cells are believed to cause an catabolic imbalance in the body. This catabolic imbalance can be analyzed and diagnosed by blood and urine analyses. A low eosinophilia (below 100/cmm), a high red cell sedimentation rate (above 15 ml/1 hour), a high serum potassium (above 4.5 mEq), a urinary acid pH (below 7), high specific gravity (above 1.016), low surface tension (below 89 dynes/cm), and low calcium or chloride excretion are indications of an catabolic imbalance. (The opposite analyses would indicate a anabolic imbalance.)
These analyses and clinical manifestations have to be changed by the administration of the incorporated potassium compound. In a 5% potassium incorporated preparation, amounts from about 1/10 to 2 ml daily are predilectly used for the treatment of this catabolic imbalance. For other conditions with anabolic imbalances, doses from about 2 to 10 ml daily are predilectly used. In general the higher the dose used, the better are the clinical results.
Interesting results are those concerning pain, the changes induced in the lesions manifesting first an action upon pain. Manifest changes in the tumors and in the subjective manifestations of the neoplastic diseases are obtained even in a very short time. Thus, the incorporated potassium appears as a predilect treatment of the symptoms of neoplastic conditions, and possibly to the treatment of such condition themselves.
Good results were also obtained in the use of the incorporated potassium compounds for the different manifestations of AIDS (acquired immune deficiency syndrome) as well as for the ARC (AIDS related complex).
Interesting also are the results in almost all the different conditions, such as neurological conditions, epilepsy and others, the problem of cellular potassium deficiency being a general pathological occurrence. Interesting is the action of the lipidic potassium products on the viral infections.
."